Christopher Exley Selected Research

Christopher Exley Research Topics

Disease

35	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 12/2001
12	Amyloid Plaque 09/2021 - 12/2004
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 12/2004
6	Multiple Sclerosis 01/2020 - 10/2006
5	Epilepsy (Aura) 01/2022 - 01/2019
4	Genetic Predisposition to Disease (Genetic Predisposition) 04/2021 - 03/2017
4	Autistic Disorder (Autism) 04/2020 - 03/2018
4	Dementia (Dementias) 01/2020 - 12/2004
4	Breast Neoplasms (Breast Cancer) 07/2017 - 09/2007
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2004
3	Inflammation (Inflammations) 01/2021 - 10/2006
3	Autism Spectrum Disorder 01/2020 - 03/2018
3	Cognitive Dysfunction 12/2019 - 01/2015
3	Hypersensitivity (Allergy) 08/2019 - 08/2010
2	Rupture 01/2022 - 11/2013
2	Amyloid angiopathy 04/2020 - 01/2012
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2020 - 01/2019
2	Granuloma 01/2019 - 11/2015
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2017 - 02/2009
1	Neuroblastoma 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Neurodevelopmental Disorders 04/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Catalepsy 12/2019
1	Mycoses (Diseases, Fungus) 05/2018
1	Amyloidosis 01/2018
1	Chronic Progressive Multiple Sclerosis 12/2017
1	Brain Diseases (Brain Disorder) 03/2017
1	Myalgia 01/2017
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Chronic Disease (Chronic Diseases) 01/2014
1	Genomic Instability 11/2013
1	Vascular Diseases (Vascular Disease) 06/2013
1	Neurologic Manifestations (Neurological Manifestations) 04/2013
1	Type 2 Diabetes Mellitus (MODY) 10/2010
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 06/2009
1	Macrophagic myofasciitis 02/2009
1	Leishmaniasis 11/2008
1	Diabetes Mellitus 02/2008
1	Mental Disorders (Mental Disorder) 06/2007

Drug/Important Bio-Agent (IBA)

45	AluminumIBA 01/2022 - 12/2001
17	Amyloid (Amyloid Fibrils)IBA 04/2021 - 06/2004
6	Peptides (Polypeptides)IBA 09/2021 - 06/2004
6	CopperIBA 01/2012 - 06/2004
5	IronIBA 01/2012 - 06/2004
4	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2020
4	NeurotoxinsIBA 01/2019 - 02/2014
4	VaccinesIBA 01/2019 - 02/2009
4	MetalsIBA 01/2019 - 06/2004
4	Amyloid beta-PeptidesIBA 01/2010 - 10/2002
3	GraphiteIBA 01/2020 - 10/2016
3	SaltsIBA 08/2019 - 01/2014
3	Silicic AcidIBA 05/2018 - 09/2006
3	Mineral WatersIBA 12/2017 - 09/2006
3	SiliconIBA 12/2017 - 01/2013
2	Flavin-Adenine Dinucleotide (FAD)IBA 04/2021 - 01/2020
2	Amino Acids FDA Link 08/2019 - 09/2005
2	4- chloro- 3- (2,4- dihydroxyphenylazo)- 2- hydroxybenzene- 1- sulfonic acidIBA 01/2019 - 10/2016
2	aluminum sulfate (alum)IBA 11/2015 - 04/2013
2	Islet Amyloid PolypeptideIBA 10/2010 - 02/2008
2	ZincIBA 11/2006 - 06/2004
1	SphingolipidsIBA 01/2021
1	CeramidesIBA 01/2021
1	SphingomyelinsIBA 01/2021
1	PresenilinsIBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020
1	AcidsIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 12/2019
1	Protective AgentsIBA 12/2019
1	thioflavin TIBA 01/2019
1	Congo RedIBA 01/2019
1	AntigensIBA 01/2018
1	Serum Amyloid P-ComponentIBA 01/2012
1	SolutionsIBA 01/2012
1	AntibodiesIBA 08/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2010
1	Prion ProteinsIBA 06/2009
1	AntiperspirantsIBA 09/2007
1	CosmeticsIBA 09/2007
1	Heroin (Diamorphine)IBA 06/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2006
1	Biomarkers (Surrogate Marker)IBA 10/2006
1	Thiobarbituric Acid Reactive SubstancesIBA 10/2006
1	alpha-SynucleinIBA 12/2004

Therapy/Procedure

6	Therapeutics 01/2014 - 06/2004
2	Immunotherapy 08/2019 - 01/2014
1	Subcutaneous Injections 01/2019
1	Mastectomy (Mammectomy) 10/2013
1	Chelation Therapy (Therapy, Chelation) 06/2004